ANL logo

ANL
Adlai Nortye Ltd. American

285
Mkt Cap
$489.99M
Volume
13,525.00
52W High
$17.25
52W Low
$0.8786
PE Ratio
-14.18
ANL Fundamentals
Price
$13.74
Prev Close
$14.27
Open
$14.23
50D MA
$10.22
Beta
0.00
Avg. Volume
182,655.28
EPS (Annual)
-$1.11
P/B
-68.59
Rev/Employee
$45,992.88
$47.99
Loading...
Loading...

About

Adlai Nortye Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of development of cancer therapies for patients with stages of tumors. It offers AN0025, a clinical stage, potential EP4 antagonist designed to modulate tumor microenvironment. The company was founded on May 9, 2018, and is headquartered in Hangzhou, China.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
109

Frequently Asked Questions

What is Market Cap of Adlai Nortye Ltd. - ADR?
What is the 52-week high for Adlai Nortye Ltd. - ADR?
What is the 52-week low for Adlai Nortye Ltd. - ADR?
What is Adlai Nortye Ltd. - ADR stock price today?
What was Adlai Nortye Ltd. - ADR stock price yesterday?
What is the PE ratio of Adlai Nortye Ltd. - ADR?
What is the Price-to-Book ratio of Adlai Nortye Ltd. - ADR?
What is the 50-day moving average of Adlai Nortye Ltd. - ADR?
How many employees does Adlai Nortye Ltd. - ADR have?

Latest ANL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.